Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 473, pseudogene (RN7SL473P)

Target
RN7SL473P
Molecular classification
Pseudogene, Non-coding RNA, Processed RNA pseudogene
01

Overview

RN7SL473P, also known as RNA, 7SL, cytoplasmic 473, pseudogene, is classified as a pseudogene of the 7SL RNA, which is an RNA component of the signal recognition particle (SRP)[1][3][5][8]. Unlike functional protein-coding genes or therapeutic targets, pseudogenes like RN7SL473P are generally considered non-functional remnants of once-active genes; they arise through retrotransposition or gene duplication, and the majority do not encode functional RNA or protein products[1][5][8]. The parent 7SL RNA serves as a scaffold RNA for the SRP complex in protein targeting within the cell, but RN7SL473P itself does not participate in this process[7][1]. A large number of such 7SL RNA-related pseudogenes exist in the human genome; they are not actively transcribed or translated, and they do not have any known therapeutic relevance, mechanism of drug action, or established use as biomarkers. The gene is clearly annotated as a pseudogene and is not considered a therapeutic, diagnostic, or research target in current biomedical contexts[1][5][8]. There is nothing to indicate that "RNA, 7SL, cytoplasmic 473, pseudogene" is a misspelling, but it is not a targetable molecule in drug discovery or clinical applications[1][7][8]. If you require structured information for protein-coding members of the SRP RNA family, refer to the functional 7SL RNA genes (such as RN7SL1) rather than this pseudogene locus.

Other names
RN7SL473P
02

Biological functions

No known functionNon-functional remnant
03

Disease associations

No established disease role

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 473, pseudogene (RN7SL473P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 473, pseudogene (RN7SL473P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call